ResMed Inc. (NYSE:RMD – Get Free Report) CEO Michael J. Farrell sold 14,683 shares of the stock in a transaction dated Friday, June 7th. The stock was sold at an average price of $211.66, for a total transaction of $3,107,803.78. Following the transaction, the chief executive officer now directly owns 440,799 shares of the company’s […]
Quadrature Capital Ltd trimmed its position in ResMed Inc. (NYSE:RMD – Free Report) by 71.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 56,379 shares of the medical equipment provider’s stock after selling 140,824 shares during the quarter. Quadrature Capital Ltd’s holdings in […]
Nicholas Company Inc. lessened its stake in shares of ResMed Inc. (NYSE:RMD – Free Report) by 0.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 78,395 shares of the medical equipment provider’s stock after selling 250 shares during the quarter. Nicholas Company Inc. […]